Tuesday, September 23, 2025 9:57:28 AM
Written Consent of the Independent Bankruptcy Committee of
ProPhase Diagnostics NY, Inc.
The undersigned, Derek DeStefano, sole member and Chair of the Independent Bankruptcy
Committee of ProPhase Diagnostics NY, Inc., a Delaware corporation, acting pursuant to Section
141(f) of the Delaware General Corporation Code, does hereby adopt the following resolutions
by unanimous written consent in lieu of a meeting and directs that this consent be filed with the
minutes of proceedings of the board of directors of the Corporation.
WHEREAS, the Board of Directors has delegated authority to the Independent Bankruptcy
Committee (“IBC”); and
WHEREAS, Mr. DeStefano is the sole member and Chair of the IBC;
IT IS THEREFORE resolved as follows:
RESOLVED, that it is in the best interests of the Corporation to initiate a case in Chapter 11
Reorganization under the U.S. Bankruptcy Code;
FURTHER RESOLVED, that the Corporation shall intiate a Chapter 11 Reorganization under
Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the
District of New Jersey (Trenton vicinage), including seeking joint administration with cases of
affiliated entities if advisable, and to execute, deliver, and file all petitions, schedules, motions,
applications, and other documents in connection therewith.
FURTHER RESOLVED, that the Corporation is authorized to employ and retain Thaddeus R.
Maciag, Esq. and Maciag Law LLC as bankruptcy counsel to the Corporation, and to retain such
other professionals as may be necessary or desirable, including qualified accounting firms and
special litigation counsel, in each case on such terms as may be approved by the Bankruptcy
Court; and
FURTHER RESOLVED, pursuant to the foregoing, that the Corporation is further authorized
to, if the IBC deems it necessary, retain on behalf of the Corporation (a) qualified accounting
firm to render accounting and other services to the Corporation; and (b) Special Litigation
Counsel, to render litigation services to the Corporation, in connection with the Chapter 11
proceedings, the restructuring of the Corporation’s assets and liabilities, and other related
matters, on such terms as the Bankruptcy Court may approve.
IN WITNESS WHEREOF, the undersigned sole member and Chair of the IBC has executed
this Unanimous Written Consent as of September 21, 2025.
PROPHASE DIAGNOSTICS NY, INC.
a Delaware corporation
(as Sole Member and Chair of the IBC)
Case 25-19836-CMG Doc 2 Filed 09/22/25 Entered 09/22/25 02:38:37 Desc Main
Document Page 1 of 8
ProPhase Diagnostics NY, Inc.
The undersigned, Derek DeStefano, sole member and Chair of the Independent Bankruptcy
Committee of ProPhase Diagnostics NY, Inc., a Delaware corporation, acting pursuant to Section
141(f) of the Delaware General Corporation Code, does hereby adopt the following resolutions
by unanimous written consent in lieu of a meeting and directs that this consent be filed with the
minutes of proceedings of the board of directors of the Corporation.
WHEREAS, the Board of Directors has delegated authority to the Independent Bankruptcy
Committee (“IBC”); and
WHEREAS, Mr. DeStefano is the sole member and Chair of the IBC;
IT IS THEREFORE resolved as follows:
RESOLVED, that it is in the best interests of the Corporation to initiate a case in Chapter 11
Reorganization under the U.S. Bankruptcy Code;
FURTHER RESOLVED, that the Corporation shall intiate a Chapter 11 Reorganization under
Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the
District of New Jersey (Trenton vicinage), including seeking joint administration with cases of
affiliated entities if advisable, and to execute, deliver, and file all petitions, schedules, motions,
applications, and other documents in connection therewith.
FURTHER RESOLVED, that the Corporation is authorized to employ and retain Thaddeus R.
Maciag, Esq. and Maciag Law LLC as bankruptcy counsel to the Corporation, and to retain such
other professionals as may be necessary or desirable, including qualified accounting firms and
special litigation counsel, in each case on such terms as may be approved by the Bankruptcy
Court; and
FURTHER RESOLVED, pursuant to the foregoing, that the Corporation is further authorized
to, if the IBC deems it necessary, retain on behalf of the Corporation (a) qualified accounting
firm to render accounting and other services to the Corporation; and (b) Special Litigation
Counsel, to render litigation services to the Corporation, in connection with the Chapter 11
proceedings, the restructuring of the Corporation’s assets and liabilities, and other related
matters, on such terms as the Bankruptcy Court may approve.
IN WITNESS WHEREOF, the undersigned sole member and Chair of the IBC has executed
this Unanimous Written Consent as of September 21, 2025.
PROPHASE DIAGNOSTICS NY, INC.
a Delaware corporation
(as Sole Member and Chair of the IBC)
Case 25-19836-CMG Doc 2 Filed 09/22/25 Entered 09/22/25 02:38:37 Desc Main
Document Page 1 of 8
Recent PRPH News
- ProPhase Labs Reports Year-End 2025 Results, Highlights Accelerating Settlement Activity and Investment-Ready Crown Medical Collections Platform • GlobeNewswire Inc. • 04/15/2026 01:05:00 PM
- ProPhase Labs Provides Business Update Highlighting Advancing Crown Medical Collections Activity • GlobeNewswire Inc. • 03/17/2026 12:00:00 PM
- ProPhase Labs Initiates Potential Sale or Strategic Partnership of BE-Smart™ and Advances Crown Medical Collections Initiative • GlobeNewswire Inc. • 02/03/2026 12:00:00 PM
- Join ProPhase Labs’ Exclusive Live Investor Webinar and Q&A Session on February 3rd • GlobeNewswire Inc. • 02/02/2026 01:00:00 PM
- ProPhase Labs Provides Crown Medical Collections Update; 250+ Insurance Payors Engaged, Approximately 50 Matters in Advanced Settlement Posture • GlobeNewswire Inc. • 01/26/2026 12:00:00 PM
- ProPhase Labs Uplists from Pink Sheets to OTC Market • GlobeNewswire Inc. • 01/22/2026 12:00:00 PM
- ProPhase Labs Provides Update on Convertible Debt Conversions, Capital Structure, and Underlying Asset Value • GlobeNewswire Inc. • 01/05/2026 10:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:10:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/29/2025 10:04:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2025 08:37:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2025 06:07:33 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/19/2025 06:03:21 PM
- ProPhase Labs Signs Non-Binding LOI for Proposed Reverse Merger with Advanced Biological Laboratories • GlobeNewswire Inc. • 12/19/2025 12:00:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/18/2025 06:30:45 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/12/2025 04:41:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/26/2025 07:15:29 PM
- Join ProPhase Labs’ Exclusive Live Investor Webinar and Q&A Session on December 1 • GlobeNewswire Inc. • 11/26/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/25/2025 09:30:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/25/2025 09:30:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/19/2025 09:06:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/19/2025 02:00:52 PM
- ProPhase Labs Reported Results for the Third Quarter Ended September 30, 2025, and Will Hold a Virtual Conference Call Today at 2pm ET. • GlobeNewswire Inc. • 11/19/2025 01:13:06 PM
- ProPhase Labs, Inc. to Present Third Quarter 2025 Financial Results on November 19 • GlobeNewswire Inc. • 11/18/2025 01:00:00 PM
- ProPhase Labs Urges Shareholders to Vote by November 23 on Proxy Proposals • GlobeNewswire Inc. • 11/17/2025 01:00:00 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2025 09:15:04 PM
